The class III POU-domain transcription factor SCIP/Oct-6 is expressed by promyelinating Schwann cells and, in tissue culture, by oligodendrocyte progenitors (OPs), but is down-regulated in both cells types as they differentiate. Although the expression of SCIP/Oct-6 has been examined in peripheral nerve remyelination, its expression in CNS remyelination has not been addressed. Using a toxin model of demyelination, in which the demyelinated axons are remyelinated in an age-dependent manner by both oligodendrocytes and Schwann cells, we have compared the expression of SCIP/Oct-6 mRNA with that of an OP marker (PDGF-␣R), a marker of myelinating oligodendrocytes (PLP), and markers of myelinating Schwann cells (P 0 and Krox-20) by in situ hybridization. We have found that the expression of SCIP/Oct-6 mRNA precedes that of P 0 and Krox-20 mRNA expression, but bears little correlation with the expression profiles of either PDGF-␣R or PLP mRNA. Moreover, there is a spatial correlation between the expression SCIP/Oct-6 mRNA and that of P 0 but not of PDGF-␣R. These results indicate that SCIP/Oct-6 expression following CNS demyelination is associated with Schwann cell and not oligodendrocyte remyelination. We have also shown that another POU-domain transcription factor, Brn-2, is expressed during CNS remyelination, but that like SCIP/Oct-6, it too has an expression profile indicating that it is associated with the Schwann cell component of remyelination. In addition, we show that Brn-2 expression in Schwann cells is not restricted to CNS remyelination but is also expressed in a similar manner to SCIP/Oct-6 during Schwann cell myelination of neonatal peripheral nerves and regenerating transected adult nerve and in cultured Schwann cells following induction of elevated cAMP levels.
INTRODUCTION
Our understanding of the transcriptional control of the development of oligodendrocytes and Schwann cells, and of their differentiation into myelin-sheathforming cells, although incomplete, has made significant advances in recent years (Mandemakers et al., 1999; Wegner, 2000a Wegner, ,b, 2001 Hudson, 2001 ). An issue that has received less attention is the expression of transcription factors associated with the process of myelin regeneration (remyelination) following demyelination in the adult CNS (Sim et al., 2000) . In this study we have examined the expression of the POU-domain transcription factor SCIP/Oct-6 during the remyelination that follows toxin-induced demyelination of the adult rat brain.
SCIP/Oct-6 is expressed in cells of both the Schwann cell and the oligodendrocyte lineages. In the peripheral nervous system its expression has been well characterized and its function explored using a variety of transgenic and gene knockout strategies (Monuki et al., 1989; Scherer et al., 1994; Jaegle et al., 1996; Bermingham et al., 1996; Arroyo et al., 1998; Gondre et al., 1998; Mandemakers et al., 2000) . Although SCIP/Oct-6 can be detected in Schwann cell precursors (Blanchard et al., 1996; Lobsiger et al., 2001) , it is most highly expressed by promyelinating Schwann cells during developmental myelination and during myelination of regenerating axons following crush injury in the adult (Monuki et al., 1989; Scherer et al., 1994; Jaegle et al., 1996; Zorick et al., 1996; Arroyo et al., 1998) . SCIP/Oct-6 knockout mice exhibited a delay in peripheral myelination that is associated with the transient arrest of Schwann cell differentiation at the promyelinating stage (Jaegle et al., 1996; Bermingham et al., 1996) . This has led to the suggestion that its essential role may be as a "competence factor" acting via transcriptional regulation of a set of genes that allow the normal progression of Schwann cell differentiation.
The role of SCIP/Oct-6 in the oligodendrocyte lineage has proven more difficult to resolve. The detection of SCIP/Oct-6 mRNA in neonatal rat optic nerve but not in cultured astrocytes suggested that it may be expressed by oligodendrocyte lineage cells (Monuki et al., 1989) . It was subsequently shown in tissue culture that oligodendrocyte progenitors (OPs) express SCIP/ Oct-6, with levels declining sharply as the cells differentiate into more mature stages of the lineage Bogler et al., 1993; Schreiber et al., 1997) . Prolonged expression of SCIP/Oct-6 in more mature stages of the lineage in a transgenic mouse containing a SCIP/Oct-6 transgene under the control of the MBP promoter results in CNS myelination abnormalities (Jensen et al., 1998) . However, in contrast to the striking effects on the peripheral nervous system, there is no apparent abnormality in CNS myelination in the SCIP/ Oct-6 knockout mice (Jaegle et al., 1996; Bermingham et al., 1996) . It has been proposed that the reason for this discrepancy is that other members of the POU-domain family of transcription factors, in which there is considerable redundancy of function, compensate for the absence of SCIP/Oct-6 in the CNS. However, while the expression of POU-domain family members Brn-1 and Brn-2 by primary OPs and an OP cell line in tissue culture is consistent with this explanation , it has not been shown which, if any, of these factors are expressed by oligodendrocyte lineage cell in vivo, either during development or during remyelination.
In this study we have used a model of demyelination in which the subsequent remyelination is by both oligodendrocytes and Schwann cells (Woodruff and Franklin, 1999; Shields et al., 1999) . This has enabled us to relate the expression of SCIP/Oct-6 to markers specific to both types of remyelination. Moreover, we have used the age-dependent decline in remyelination to demonstrate that changes in SCIP/Oct-6 expression correlate with the expression of remyelination markers independently of the rate at which it occurs. This provides evidence that the changes in transcription factor expression are related to the remyelination process (Shields et al., 1999; Sim et al., 2000) .
RESULTS

SCIP/Oct-6 mRNA Is Expressed during CNS Remyelination Following Ethidium-BromideInduced Demyelination of the Adult Rat Caudal Cerebellar Peduncle
To investigate the expression profile of SCIP during CNS remyelination, we induced demyelination in the caudal cerebellar peduncle of young (2 months) and old (Ͼ12 months) adult rats by the stereotaxic injection of ethidium bromide (EB). These demyelinated lesions undergo spontaneous remyelination at a rate determined by the animal's age (Shields et al., 1999) . The remyelination is predominantly by oligodendrocytes but there is also a contribution from Schwann cells, especially around blood vessels in the center of the lesion (Fig. 1) . SCIP/Oct-6 mRNA expression was examined using in situ hybridization with an oligonucleotide probe previously shown to specifically bind SCIP/Oct-6 mRNA .
Increased SCIP/Oct-6 mRNA expression was initially detected in the center of the demyelinated lesion (Fig.  2a) . This occurred at 14 days post-lesion induction (dpl) in young animals and 7 days later at 21 dpl in old animals. The level of SCIP/Oct-6 mRNA expression in young animals was significantly higher than those in old animals until 28 dpl when the levels of expression in both age groups were equivalent (Fig. 2b) . SCIP/Oct-6 expression was still detectable, albeit at lower levels, at 66 dpl in both age groups, even though remyelination is complete at this time (Shields et al., 1999) . This observation that is consistent with the prolonged expression of SCIP/Oct-6 found following sciatic nerve-crush-induced peripheral remyelination (Toews et al., 1991; Scherer et al., 1994) .
Oligodendrocyte and Schwann Cell Lineage Marker Expression during CNS Remyelination
Since SCIP/Oct-6 is expressed by both myelinating Schwann cells and, at least in tissue culture, by OPs Bogler et al., 1993) , we next compared the pattern of SCIP/Oct-6 expression with those of Schwann cell and oligodendrocyte lineage markers to establish whether it followed more closely that of oligodendrocyte or Schwann cell remyelination. The OP response was established by using the mRNA expression pattern of PDGF-␣R (Fig. 3) (Pringle et al., 1992) . The mature stages of the oligodendrocyte lineage were investigated by the expression of the myelin protein gene PLP (Fig. 4) . The PLP oligonucleotide probe used binds both PLP and DM20 mRNAs (Hudson et al., 1987; Woodruff and Franklin, 1998) . Since PLP/DM20 is expressed by some OPs during development (Dickinson et al., 1996; Spassky et al., 1998) , it was possible that it might also label a proportion of OPs as well as myelinating oligodendrocytes. However, we have previously shown that the pattern of PLP mRNA expression matches both MBP and the oligodendrocyte lineagespecific transcription factor, Gtx (Sim et al., 2000) . The patterns of expression within the lesion were quantified using image analysis (Figs. 3b and 4b) .
The pattern of peripheral-type remyelination was investigated by examination of the mRNA expression of the peripheral myelin protein, P 0 , and the transcription factor, Krox-20, which is expressed by Schwann cells but not oligodendrocyte lineage cells (Topilko et al., 1994; Sock et al., 1997) . Both P 0 and Krox-20 mRNAs were initially found in the lesion center (Fig. 5) , in a pattern of expression that corresponded to the pattern of Schwann cell remyelination identified morphologically ( Fig. 1c) (Woodruff and Franklin, 1999; Shields et al., 1999) , and by P 0 immunocytochemistry (Fig. 1d) . Increased P 0 mRNA was not found until 14 dpl, approximately 7 days after the reappearance of PLP mRNA, indicating that the onset of formation of peripheral-type myelin sheaths occurs after that of central-type myelin sheaths. The patterns of P 0 and Krox-20 mRNA expression in old animals indicate that not only central but also peripheral-type remyelination is delayed in agedadult rats (Fig. 6 ).
The Pattern of SCIP/Oct-6 mRNA Expression Indicates an Association with Schwann Cell Remyelination and Not Oligodendrocyte Remyelination
The patterns of both oligodendrocyte and Schwann cell remyelination were compared with SCIP/Oct-6 mRNA by calculating the relative expression of each marker mRNA to their peak expression and plotting against relative SCIP/Oct-6 mRNA expression (Fig. 7) . If SCIP/Oct-6 were expressed by OPs during remyelination then one would predict similar expression patterns for both SCIP/Oct-6 and PDGF-␣R. However, the SCIP/Oct-6 mRNA expression pattern was strikingly different from that of PDGF-␣R in both age groups, with the onset of SCIP expression occurring several days after that of the OP marker. Moreover, at the earlier survival times the SCIP/Oct-6 expression even lagged behind that of the oligodendrocyte marker, PLP. These data suggest that oligodendrocyte lineage cells do not express SCIP/Oct-6 during remyelination. In contrast, the SCIP/Oct-6 mRNA profile was very similar to that of both the Schwann cell markers, P 0 and Krox-20. SCIP/Oct-6 mRNA expression slightly preceded that of P 0 and Krox-20, being detected 4 days earlier and reaching peak levels of expression at 21 dpl. This pattern of expression is consistent with the patterns of SCIP/Oct-6, P 0 , and Krox-20 mRNA expression during peripheral myelination and suggested that SCIP/Oct-6 expression in this lesion model was primarily due to Schwann cell expression. To confirm that SCIP/Oct-6 expression was more closely related to that of Schwann-cell-specific mRNA rather than with an OP marker, we compared the expression of SCIP/Oct-6 with P 0 and PDGF-␣R on serial sections of young animals at 21 and 28 days following lesion induction using digoxygenin-labeled riboprobes. These survival times were chosen because of the high levels of SCIP expression (Fig. 2) . This revealed that the expression of SCIP/ Oct-6 occurred in similar areas of the lesion to those in which P 0 -expressing cells were located, but was less widespread than that of PDGF-␣R-expressing cells, which were frequently located in areas where there was no SCIP/Oct-6 expression ( Fig. 8 ). 
FIG. 2. (a)
Expression pattern of SCIP/Oct-6 mRNA during remyelination of EB-induced demyelination of the caudal cerebellar peduncle in both young and old adult animals. Sections through the center of the lesion were hybridized with 33 P-labeled SCIP-specific oligonucleotide probes using a standard in situ hybridization protocol. Representative autoradiograms demonstrate the resulting hybridization signal at 14, 21, 28, and 66 days post-lesion induction. No significant increase in SCIP mRNA levels could be detected at the earlier time points examined (2, 5, 7, and 10 days post-lesion induction). Bar, 500 m. (b) Changes in mean relative optical density (ROD) measurements (ϮSEM) for SCIP/Oct-6 mRNA expression within EBinduced lesions between 2 and 66 days post-lesion induction (dpl) in young and old adult animals. (*Significant difference in SCIP/Oct-6 mRNA expression between young and old animals at a specific time point.)
Brn-2 mRNA Is Expressed Following CNS Demyelination with a Pattern More Consistent with That of Schwann-Cell-Type Remyelination Than Oligodendrocyte Remyelination
Since SCIP/Oct-6 was not associated with oligodendrocyte remyelination we next addressed whether other class III POU-domain transcription factors might be expressed by oligodendrocyte lineage cells, a possibility that has been suggested to account for the absence of a CNS myelin phenotype in SCIP/Oct-6 knockout mice . We therefore designed oligonucleotide probes to two other members of the class III POU-domain family, Brn-1 and Brn-2, and tested their specificity by Northern blot analysis ( Fig. 9 ) and by examining their expression pattern in neonatal rat brain with in situ hybridization (data not shown) (He et al., 1989; Alvarez-Bolado et al., 1995) . Furthermore, when Brn-2 in situ hybridization was performed on adult cerebellar tissue, Brn-2 mRNA expression was observed in the deep cerebellar nuclei as previously reported (Fig. 10a) (He et al., 1989; Alvarez-Bolado et al., 1995) .
We examined the mRNA expression of both these transcription factors following EB injection and were unable to detect increased Brn-1 mRNA expression at any time point in either age group. However, increased levels of Brn-2 mRNA expression were detected within lesions at 14 dpl in young animals and at 21 dpl in old animals (Fig. 10a) . In a similar manner to the SCIP/ Oct-6 mRNA expression profile, the pattern of Brn-2 mRNA expression more closely correlated with that of P 0 and Krox-20 than with PDGF-␣R, suggesting that it too was associated with Schwann cell remyelination but not oligodendrocyte remyelination (Fig. 11 ).
In the Peripheral Nervous System, Brn-2 mRNA Is Expressed during Sciatic Nerve Myelination and Remyelination
Although Brn-2 mRNA has been detected in the RT4 peripheral stem cell line (Donahue and Reinhart, 1998) , FIG. 5. Expression pattern of P 0 and Krox-20 mRNAs during remyelination of EB-induced demyelination of the caudal cerebellar peduncle in both young and old adult animals. Sections through the center of the lesion were hybridized with 35 S-labeled oligonucleotide probes using a standard in situ hybridization protocol. Representative autoradiograms demonstrate the resulting hybridization signal at 14, 21, 28, and 66 days post-lesion induction. No increase in either P 0 or Krox-20 mRNA could be detected at earlier time points examined (2, 5, 7, and 10 days post-lesion induction). (Arrowhead indicates area of high P 0 mRNA expression in 8th cranial nerve.) Bar, 500 m.
FIG. 4. Expression of PLP mRNA following EB-induced demyelination of the caudal cerebellar peduncle. (a)
In situ hybridization using 35 S-labeled oligonucleotide probes specific to PLP mRNA. Representative autoradiograms are shown at 5 and 21 days post-lesion induction (see Sim et al., 2000) . Bar, 500 m. (b) Changes in mean relative optical density (ROD) measurements (ϮSEM) for PLP mRNA expression within EB-induced lesions between 2 and 66 days post-lesion induction (dpl) in young and old adult animals.
there are currently no reports of Brn-2 expression by Schwann cells in the normal developing PNS. We therefore next addressed whether the expression of Brn-2 during formation of peripheral type myelin was peculiar to Schwann remyelination of the CNS or whether it was a consistent feature of myelin sheath formation by Schwann cells in general. RT-PCR analysis was performed on RNA extracted both from developing sciatic nerve and from the distal portion of crushed sciatic nerve undergoing spontaneous remyelination (Fig.  12a ). In agreement with previous studies, SCIP/Oct-6 mRNA was detected at high levels during the first postnatal week during myelination and then declined in the adult (Zorick et al., 1996; Arroyo et al., 1998) . In addition, only the distal portion of the crushed nerve, where the regenerating axons are undergoing myelination, showed significant SCIP/Oct-6 mRNA induction (Monuki et al., 1990; Scherer et al., 1994; Zorick et al., 1996; Arroyo et al., 1998) . The pattern of Brn-2 expression was similar to the pattern of SCIP/Oct-6 mRNA expression in both neonatal and regenerating adult peripheral nerve, suggesting that Brn-2 mRNA was regulated in a similar manner to SCIP during formation of peripheral type myelin sheaths (Fig. 12a) .
Expression of Brn-2 mRNA Is Induced in a Similar Fashion to SCIP/Oct-6 Following Increased Intracellular cAMP in Vitro
The RT-PCR data on RNAs extracted from peripheral nerve did not per se indicate that Brn-2 was expressed by myelinating Schwann cells. To show expression of Brn-2 mRNA by Schwann cells, we performed RT-PCR analysis on cultures of purified primary Schwann cells (Ͼ95%). Both SCIP/Oct-6 and Brn-2 mRNA were detected in untreated cultures (Fig. 12b) . Furthermore, when these cells are stimulated by increasing intracellular cAMP concentrations with 20 M forskolin both SCIP/Oct-6 and Brn-2 mRNAs expression increased (Monuki et al., 1989) (Fig. 12b) . This indicated that that Brn-2 mRNA is expressed by Schwann cells and that expression of both SCIP/Oct-6 and Brn-2 mRNAs is induced following increased intracellular cAMP. Thus, in vivo during PNS development and remyelination, both in the PNS and in the CNS, and in vitro the class III POU-domain transcription factor Brn-2 would appear to be expressed in a similar manner to SCIP/Oct-6.
DISCUSSION
In this study we have examined the mRNA expression of the POU-domain transcription factor SCIP/ Oct-6 during the remyelination of demyelinated axons in the adult CNS. This transcription factor has welldocumented roles in Schwann cell myelination in the peripheral nervous system, but although expressed by OPs in vitro its function in OP biology in vivo remains uncertain. Within the oligodendrocyte lineage its level of expression is highest in OPs and decreases dramatically as they differentiate into mature oligodendrocytes Bogler et al., 1993; Schreiber et al., 1997) . We have used a model in which remyelination is by both oligodendrocytes and Schwann cells, enabling us to examine the expression of SCIP/Oct-6 in both cell types (Woodruff and Franklin, 1999) .
The process of oligodendrocyte remyelination following EB-induced demyelination is predominantly mediated by the recruitment of adult OPs into the area of demyelination by proliferation and, to a lesser extent, migration and their subsequent differentiation into oligodendrocytes that reinvest the demyelinated axons with new myelin sheaths (Gensert and Goldman, 1997; Franklin et al., 1997; Levine and Reynolds, 1999) . The recruitment phase of remyelination can be followed using markers such as PDGF-␣R, while the oligodendrocyte differentiation can be followed by the expression of PLP mRNA (Sim et al., 2000; Sim et al., 2002) . If SCIP/Oct-6 were expressed by OPs during oligodendrocyte-mediated remyelination then one would pre- dict that its expression profile would follow that of the OP marker and decline during the differentiation phase revealed by the accumulating levels of PLP mRNA.
Moreover, the SCIP/Oct-6 profile should match that of the OP marker regardless of the rate at which OP recruitment is occurring. To test these predictions we
FIG. 7.
Comparison of the SCIP/Oct-6 mRNA expression pattern with markers of both the oligodendrocyte lineage (PDGF-␣R-OPs and PLP-mature oligodendrocyte mRNAs) and the Schwann cell lineage (P 0 mRNA). The expression levels are indicated as a proportion of their peak levels of expression. dpl, days post-lesion induction.
FIG. 8.
Serial sections from a 21-day ccp lesion in a young adult rat indicating the spatial distribution of (a) P 0 , (b) SCIP/Oct-6, and (c) PDGF-␣R following in situ hybridization. The pattern of SCIP/Oct-6 mRNA expression closely resembles that of the Schwann cell marker P 0 , but is clearly different from that of the OP marker, PDGF-␣R. Bar, 80 m.
induced demyelination by stereotaxic injection of EB into the caudal cerebellar peduncles of young adult rats and old adult rats. The rate of OP recruitment, and indeed the rate of remyelination, is significantly slower in the older age group compared to the younger (Shields et al., 1999; Sim et al., 2002) . One would therefore predict differences in the SCIP/Oct-6 profile between the two age groups. However, although SCIP/ Oct-6 mRNA expression was detected during the remyelination of EB-induced demyelination, the spatial and temporal expression profile bore no resemblance to that of the OP markers and indeed in some instances occurred after the onset of PLP expression. Instead, the expression of SCIP/Oct-6 occurred shortly before and with a similar profile to the expression of the mRNA of the peripheral myelin-specific protein P 0 and the transcription factor Krox-20 which is expressed shortly after SCIP/Oct-6 in Schwann cells (Zorick et al., 1996) and is not expressed in the oligodendrocyte lineage (Topilko et al., 1994) . Thus, although SCIP/Oct-6 mRNA was clearly associated with Schwann cell remyelination, as expected, we found no evidence linking its expression to oligodendrocyte remyelination.
The absence of correlation between SCIP/Oct-6 expression during oligodendrocyte remyelination is seemingly at variance with its expression by cultured OPs. We cannot be certain of the reason for this discrepancy at present but there several possibilities. One possibility is that the expression of SCIP/Oct-6 by OPs is a peculiarity of the tissue culture environment, and it
FIG. 9.
Northern blot analysis was undertaken to verify the specificity of the novel Brn-1 and Brn-2 oligonucleotide probes used in this study. In agreement with previously published expression data (He et al., 1989; Alvarez-Bolado et al., 1995) , the Brn-1 probe binds to three transcripts and is enriched in early postnatal brain tissue, while the Brn-2 probe binds to single transcript of approximately 3 kb found in both developing CNS and various adult tissues.
FIG. 10. (a)
Expression pattern of Brn-2 mRNA during remyelination of EB-induced demyelination of the caudal cerebellar peduncle in both young and old adult animals. Sections through the center of the lesion were hybridized with 33 P-labeled Brn-2-specific oligonucleotide probes using a standard in situ hybridization protocol. Representative autoradiograms demonstrate the resulting hybridization signal at 14, 21, 28, and 66 days post-lesion induction. No significant increase in Brn-2 mRNA levels could be detected at the earlier time points examined (2, 5, 7, and 10 days post-lesion induction). (*Brn-2 mRNA expression in the deep cerebellar nuclei, as previously reported (He et al., 1989; Alvarez-Bolado et al., 1995) .) Bar, 500 m. (b) Changes in mean relative optical density (ROD) measurements (ϮSEM) for Brn-2 mRNA expression within EB-induced lesions between 2 and 66 days post-lesion induction (dpl) in young and old adult animals.
is simply not a gene expressed by OPs in the context of the in vivo environment. In support of this view no ␤-gal-positive cells are found in forebrain white matter of SCIP-LacZ heterozygote mice at P0, when myelination is occurring and OPs are abundant (Bermingham et al., 1996) . SCIP/Oct-6 is not the only POU-domain transcription factor expressed by cultured OPs, which also express Brn-1 and Brn-2, and it is the expression of these related proteins that is proposed to account for the absence of central myelin defects in the SCIP/Oct-6 knockout mouse . We found no expression of Brn-1 mRNA following demyelination. However, although Brn-2 mRNA was detected, the pattern of expression was strikingly similar to that of SCIP/Oct-6 leading to the similar interpretation that this POU-domain transcription factor was also exclusively associated with the Schwann cell component of remyelination and not the oligodendrocyte component. Apart from Brn-5 (Wu et al., 2001) , the expression of other POU-domain transcription factors in Schwann cells has not been well documented, although Brn-2 is one of many transcripts detected in microarray analysis of Krox-20-regulated genes in Schwann cells (Nagarajan et al., 2001) . In the light of a suggestion that Schwann cells found within the CNS may have a separate derivation to those of the peripheral nervous system (Keirstead et al., 1999) , we set out to establish whether expression of Brn-2 was peculiar to Schwann cell remyelination of demyelinated CNS axons or whether it was more generally expressed by myelinating Schwann cells. Using RT-PCR, we found that Brn-2 mRNA was also expressed in myelinating peripheral nerve in development and following regeneration of transected axons in adulthood. Moreover, like SCIP/Oct-6, the levels of Brn-2 mRNA in cultured Schwann cells not in contact with axons are considerably increased by forskolin-induced intracellular cAMP increase. Thus, Brn-2 mRNA appears to be expressed in Schwann cells in a similar manner to SCIP/Oct-6. Whether it performs a similar role to SCIP/Oct-6 in regulating the differentiation of a myelinating phenotype remains to be established.
EXPERIMENTAL METHODS
Creation of Ethidium Bromide Lesions in the Caudal Cerebellar Peduncles of the Adult Rat
Female Sprague-Dawley rats ("young adults," 8 -10 weeks, ϳ200 g; "old adults," ex-breeders, Ͼ12 months, Ͼ280 g) were used in all experiments. Demyelination   FIG. 11 . Comparison of the Brn-2 mRNA expression pattern during remyelination with an OP marker (PDGF-␣R mRNA) and an immature Schwann cell marker (SCIP/Oct-6 mRNA). The pattern of increased Brn-2 mRNA expression during remyelination is similar to SCIP/Oct-6 mRNA expression but not PDGF-␣R mRNA expression. dpl, days post-lesion induction.
was induced unilaterally or bilaterally by stereotaxic injection of 4 l of 0.01% EB into the caudal cerebellar peduncles using the method previously described (Woodruff and Franklin, 1999) . Anesthesia was induced using a neuroleptanalgesic combination (0.7 ml/kg Hypnorm, 0.315 mg/ml fentanyl citrate, and 10 mg/ml fluanisone, Janssen Pharmaceuticals) and diazepam (3 mg/kg, Phoenix Pharmaceuticals). The rats were placed into a stereotaxic instrument, and using standard coordinates determined from a stereotaxic atlas (Paxinos and Watson, 1986) , 4 l of 0.01% EB (Sigma Chemical Co., St. Louis, MO) was injected into one or both caudal cerebellar peduncles. Controls were injected with an equal volume of sterile saline into the contralateral peduncle in animals receiving unilateral lesions. Postoperatively, the rats were monitored for neurological signs, although a proportion showed a variable head tilt, the clinical signs were mild and rats gradually recovered over a period of about 1 week.
Tissue Processing for Histological Analysis
Rats were killed under deep anesthesia by perfusion with 4% glutaraldehyde via the left ventricle. The fixed brains were removed and postfixed overnight and 1.5-mm-thick blocks containing the caudal cerebellar peduncles were cut. Blocks were postfixed in osmium tetroxide at 4°C overnight, dehydrated through ascending ethanol washes, and embedded in TAAB resin (TAAB Laboratories, Aldermaston, UK). One-micrometer sections were cut, stained using toluidine blue, and examined by light microscopy. In addition, selected blocks were trimmed and examined by electron microscopy (Hitachi, H600) or, after resin removal, processed for immunohistochemistry using an anti-P 0 antibody. Bound antibody was identified by applying biotinylated goat anti-mouse IgG (Sigma), followed by Vectastain ABC (Vector Laboratories) and 3, 3Ј-diaminobenzidine (DAB; Sigma) to generate a colored reaction product.
Tissue Preparation for in Situ Hybridization
Groups of four to eight animals were killed at 2, 5, 7, 10, 14, 21, 28, and 66 post-lesion induction. Tissue was prepared using a similar method previously described (Hinks and Franklin, 1999) . The animals were anesthetized with halothane prior to killing by intracardiac injection of 1 ml pentobarbitone (200 mg/ml; Animalcare Ltd., York, UK). The hindbrain was rapidly removed and the tissue frozen at -30°C in iso-pentane and stored at Ϫ70°C prior to sectioning. Coronal sections of the cerebellum and brain stem (10 m) were cut on a cryostat at Ϫ18°C and freeze-thaw mounted onto polyl-lysine-coated slides. Sections were sampled every 100 m through the lesion-containing region, air-dried, and fixed using sterile 4% paraformaldehyde in phosphate buffered saline (PBS) for 5 min, rinsed twice in PBS for 1 min, dehydrated in 70% ethanol for 5 min, and then stored in 96% ethanol at 4°C until use.
Oligonucleotide Probe Synthesis and Labeling
The following antisense oligonucleotide sequences, whose efficacy, with the exception of Brn-1 and Brn-2, have been demonstrated in previously published material, were used: Brn-1, 5Ј-CCG AGT GCA CAA TGG ATC CGG CCG CGA GCA GGC TGT TCC CCG GCA (complementary to nucleotides 95-139 following the numbering of Schreiber et al., 1997) ; Brn-2, 5Ј-ACT CTC GGA GCC GGA CTG GGC GCT CTG GTT AAA GGA GCC GCG CAT (complementary to nucleotides 25-69 following the numbering of Li et al., 1993) ; Krox-20,
FIG. 12.
RT-PCR analysis of SCIP/Oct-6, Brn-2, and cyclophilin mRNAs in vivo during PNS myelination in development and remyelination of regenerated axons following peripheral nerve crush (a) and in purified primary Schwann cells in vitro, with or without exposure to forskolin (b). In each case, Brn-2 mRNA is expressed in a similar manner to SCIP/Oct-6 mRNA.
5Ј-GTG AAG GTC TGG TTT CTA GGC GCA GAG ATG GGA GCG AAG CTA CT (complementary to nucleotides 79 -122 (Inokuchi et al., 1996) ); P 0 , 5Ј-AGT GCC GTT GTC ACT GTA GTC TAG GTT GTG TAT GAC AAT GGA GCC ATC (oligonucleotide sequence previously published (Wrathall et al., 1998) ); PLP, 5Ј-TGT ACC AGT GAG AGC TTC ATG TCC ACA TCC ACA GAA CAG TGC CAC TCC (complementary to nucleotides 220 -267 in exon 2 in the mouse (Hudson et al., 1987) ); SCIP/Oct-6, GCG GCA GAT ACT GCG CGG TGG TGG CCA TGC CGC CCC GCG CCC TGC (oligonucleotide sequence previously published ). Oligonucleotide probes were synthesized to order (Amersham Pharmacia Biotech AB, Uppsala, Sweden) and dissolved in sterile water to give a stock solution of 20 ng/l.
Northern Blot Analysis
Northern blot hybridization was carried out according to a standard protocol to confirm the size and distribution of transcripts to which the Brn-1 and Brn-2 oligonucleotide probes bound (Hinks and Franklin, 1999) . Briefly, total RNA (20 g) extracted from adult and neonatal rat tissues was separated by 1% agaroseformaldehyde gel electrophoresis. The separated RNA was transferred to a nitrocellulose membrane, prehybridized, and then incubated at 42°C with hybridization buffer containing [ 32 P]dATP end-labeled oligonucleotide probe at a final concentration of 3000 cpm/l. Following hybridization, standard stringency washes were applied to remove unbound probe and washed membrane was opposed to autoradiographic film (BioMax MS-1; Eastman Kodak Company, Rochester, NY) at -70°C overnight. The transcript size was calculated by reference to standard RNA markers.
Oligonucleotide Probe in Situ Hybridization
In situ hybridization was performed using a standard protocol as previously described (Hinks and Franklin, 1999) . Oligonucleotides were end-labeled with either [
35 S]dATP (1250 Ci/mmol; New England Nuclear, Boston, MA) or [ 33 P]dATP (3000 Ci/mmol; New England Nuclear) using terminal deoxynucleotidyl transferase and purified using Sephadex columns (Microbiospin6; Bio-Rad, Hemel Hempstead, UK) and dithiothreitol was added to final concentration of 50 mM prior to dilution in hybridization buffer. PLP, P 0 , and Krox-20 probes labeled with [
35 S]dATP were diluted to 3000 cpm/l with the exception of PLP, which was diluted to 1500 cpm/l. SCIP, Brn-1, and Brn-2 probes labeled with [
33 P]dATP were diluted to 6000 cpm/l. Lesioncontaining sections of hindbrain were hybridized overnight in hybridization buffer; the following day excess unbound and nonspecifically bound probe was removed using standard stringency washes: 1ϫ standard saline citrate buffer (SSC) at room temperature for 30 min and then 1ϫ SSC at 55°C for 30 min. Slides were finally rinsed in 1ϫ SSC, dehydrated in ethanol, and air-dried. Sections were then opposed to autoradiographic film for a probe-specific period of time before development. Care was taken to standardize procedures for control and experimental sections at all stages.
Quantification of mRNA Expression
The in situ hybridization autoradiograms were analyzed using the MCID image analysis system (MCID, Model M4, Toronto, Ontario, Canada) using a similar protocol to that previously described with minor modifications (Hinks and Franklin, 1999; Sim et al., 2000) . In brief, areas of altered gene expression associated with the lesion were sampled at 100-m intervals, providing an averaged optical density reading across the area of altered expression from which the background film levels were deducted. This value was subjected to a correction factor (CF) to normalize for differences between autoradiographic films. Using the observation that normal constitutive expression levels did not vary within age groups (data not shown), the individual CFs were calculated from the ratio of mean to individual section values. All measurements were taken within the linear range of optical density levels, throughout the lesion region, and the measurements for each animal were processed independently. The data were processed with a spreadsheet (Microsoft Excel 97) and statistically analyzed using the Kruskal-Wallis test for multiple measures, followed by post hoc pairwise comparisons (Graphpad Software). P Ͻ 0.05 was taken as the minimum level of statistical significance. For probes that did not exhibit significant expression above background in control tissues, the average nonspecific tissue background was used to plot control values in data charts.
Riboprobe in Situ Hybridization
The PDGF-␣R probe was transcribed from a 1637-bp EcoRI cDNA fragment encoding most of the extracellular domain of mouse PDGF-␣R cloned into pBluescript KSϩ (a gift from Dr. N. P. Pringle and Prof. W. D. Richardson, University College London). The SCIP/ Oct-6 probe was synthesized with T7 RNA polymerase (Roche, Lewes, UK) from a 500-bp fragment of 3Ј-untranslated region of SCIP/Oct-6 gene cloned into pSP71 plasmid (a gift from Dr. D. Meijer, University of Rotterdam). The plasmid was linearized with BglII before probe synthesis. The P 0 probe was transcribed from an approximately 700-bp fragment of P 0 gene cloned into pCMV-Tag4A plasmid (a gift from Dr. J. Balsamo, University of Iowa), which was linearized by BamHI restriction endonuclease. Groups of three to six animals were perfused with 4% paraformaldehyde in PBS at 2, 5, 7, 10, 21, and 28 days post-lesion induction in young and old adult animals. Tissue was prepared for in situ hybridization performed as described by Fruttiger and co-workers (1999) , except that both the RNA polymerases and the RNA transcription reactions were run as recommended by Boehringer Mannheim Biochemica (Mannheim, Germany). Following in situ hybridization, RNA hybrids were visualized in situ by a standard digoxygenin detection protocol as described elsewhere (Fruttiger et al., 1999) . The density of the PDGF-␣R-positive cells within the lesion was assessed by image analysis (MCID, Model M4). EB-injected regions of the caudal cerebellar peduncle, identified by solochrome cyanine staining, were captured under the ϫ4 objective using a red filter to accentuate the blue-stained PDGF-␣R nuclei. The automatic target detection feature of the MCID system was employed to select positive nuclei and the threshold level was set according to the lesion background level such that all positive nuclei were selected. The valid criteria for counting a single cell were set as an area greater than 20 m 2 . The average size of PDGF-␣Rϩ cell was found to be approximately 60 m 2 . Therefore, to allow estimation of PDGF-␣Rϩ cells that appeared in "clumps," a target whose area exceeded 80 m 2 was counted as two or more cells. However, to exclude areas of above-threshold nonspecific staining like section tears and folds, targets whose area exceeded 200 m 2 were excluded. The MCID image analysis system then calculated the cell density of positive cells. Eight sections were analyzed from each animal.
Nerve Crush and RNA Extraction
The sciatic nerves of halothane-anesthetized, adult (8 -10 weeks) Sprague-Dawley rats were exposed at the level of the midfemur. Nerve crush was produced by tightly compressing the sciatic nerve with watchmaker's forceps for 30 s. Two weeks after nerve injury, the animals were sacrificed and 8-mm sections of nerve from both distal and proximal to the crush were removed. The nerves were then frozen in -30°C in isopentane and stored at Ϫ70°C prior to RNA extraction. Unlesioned sciatic nerves were obtained from animals of varying ages, from P2 to adult (8 -10 weeks). Samples were homogenized in liquid nitrogen with a mortar and pestle and total RNA was extracted using Trizol reagent (Invitrogen, Paisley, UK) as recommended in the manufacturer's protocol.
Schwann Cell Culture
Schwann cells were obtained from sciatic nerves of 6-day-old Fischer rat pups and purified using a modification of the method described by Brockes and colleagues (1979) . Cultures were treated with cytosine arabinoside (AraC, 10-5 M, Sigma, Poole, Dorset, UK) twice for a 3-day period, which was interrupted by a 2-day incubation in fresh culture medium (10% FBS-DMEM) lacking AraC. This was followed by a 45-minlong incubation with anti-Thy1.1 antibody (3:5 supernatant, Serotec, Oxford, UK) and rabbit complement (1:6, Harlan Olac Ltd) at 37°C to reduce the contamination by fibroblasts. Following the complement mediated cytolysis the cells were washed twice in DMEM (Invitrogen), replated in T25 culture flasks (Nunc, UK), and then expanded to 80% confluency in fresh 10% FBS-DMEM supplemented with 2 M forskolin and 20 ng/ml GGF-2. Before the purified Schwann cells (Ͼ95%) were subjected to RT-PCR for SCIP/Oct-6 mRNA detection, the cells were washed free of mitogens, cultured in fresh medium alone for 5 days. One culture was exposed to 20 M forskolin, the other was fed and cultured in the same medium for a further period of 36 h prior to RNA extraction, as described above.
Reverse Transcription and PCR
RNA (1 g) was reverse-transcribed into cDNA using oligo(dT) 15-mer as primer and M-MLV reverse transcriptase (Promega) and as recommended in the manufacturer's protocol. 0.5-1.0 l of the reverse transcription reaction was used for subsequent PCR with various oligonucleotide primer pairs: SCIP (5Ј-ATT CCC CGG GAG AAT GGA CGA AAA GAG GAG AGT CC and 5Ј-AGG TGC GAG AAG AGG CGC GGA AAG AAT AAA GTG AC, modified for rat sequence from Blanchard et al., 1996) , Brn-2 (5Ј-CAC CAC GCT GCC AAC AAC CA and 5Ј-CTG GCC GAG GAT GAG TCT GC, from Schreiber et al., 1997) , cyclophilin (5Ј-TGA GCA CTG GGG AGA AAG and 5Ј-AGG GGA ATG AGG AAA ATA TGG, modified from Semple-Rowland et al., 1995) . In addition to 7.5 pmol of each primer in a selected pair, PCR reactions contained 23-24 l MegaMix Blue PCR reagent (Helena Biosciences, Sunderland, UK). After denaturation (2 min at 95°C), 25 (cyclophilin) or 35 (SCIP and Brn-2) cycles were performed with each cycle consisting of a denaturation (30 s at 94°C), an annealing (30 s at 62, 60, or 55°C for SCIP, Brn-2, or cyclophilin respectively), and an elongation step (45 s at 72°C). Finally, an extended elongation step was performed (10 min at 72°C). Amplification products were analyzed on 2% agarose gels.
